Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 951 - 975 of 2342 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass ▲ Formula
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AF04
  • GalNAcbeta1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • type II A antigen(d18:1/22:0)
44261015 1659.981127 C80H145N3O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CG04
  • ClcNAc-Lex-5(d18:1/22:0)
  • GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44261439 1659.981127 C80H145N3O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CU04
  • GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • type II A antigen(d18:1/22:0)
44261543 1659.981127 C80H145N3O32
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BI04
  • Fucalpha1-3GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44261695 1659.981127 C80H145N3O32
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BB02
  • GalNAcalpha1-3GalNAcbeta1-3(GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44260381 1660.939991 C78H140N4O33
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AL02
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44261901 1660.939991 C78H140N4O33
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AQ07
  • GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44260298 1660.965143 C80H144N2O33
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BF07
  • Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44260418 1660.965143 C80H144N2O33
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BA07
  • Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44261634 1660.965143 C80H144N2O33
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AQ05
  • GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44260296 1662.980793 C80H146N2O33
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BF05
  • Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44260416 1662.980793 C80H146N2O33
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BA05
  • Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44261632 1662.980793 C80H146N2O33
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AW01
  • Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44260340 1671.881869 C76H137NO38
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AI08
  • Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
  • type IV H(d18:1/26:1(17Z))
44260235 1673.001528 C82H148N2O32
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BM08
  • Fucalpha2-3Galbeta1-3GalNAcbeta1-4Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44260475 1673.001528 C82H148N2O32
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AK08
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44260571 1673.001528 C82H148N2O32
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AE08
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
  • type I B antigen(d18:1/26:1(17Z))
44260651 1673.001528 C82H148N2O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AE08
  • Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
  • type II B antigen(d18:1/26:1(17Z))
44261011 1673.001528 C82H148N2O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CV08
  • Gala 1-3Lex(d18:1/26:1(17Z))
  • Galalpha1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44261555 1673.001528 C82H148N2O32
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AW08
  • Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44261619 1673.001528 C82H148N2O32
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BB08
  • Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44261643 1673.001528 C82H148N2O32
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AI06
  • Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0)
  • type IV H(d18:1/26:0)
44260233 1675.017178 C82H150N2O32
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BM06
  • Fucalpha2-3Galbeta1-3GalNAcbeta1-4Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44260473 1675.017178 C82H150N2O32
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AK06
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44260569 1675.017178 C82H150N2O32
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AE06
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
  • type I B antigen(d18:1/26:0)
44260649 1675.017178 C82H150N2O32

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024